<?xml version="1.0" encoding="UTF-8"?><?xml-stylesheet type="text/xsl" href="static/style.xsl"?><OAI-PMH xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd"><responseDate>2026-09-05T05:48:49Z</responseDate><request verb="GetRecord" identifier="oai:gredos.usal.es:10366/155367" metadataPrefix="didl">https://gredos.usal.es/oai/request</request><GetRecord><record><header><identifier>oai:gredos.usal.es:10366/155367</identifier><datestamp>2025-04-30T20:41:42Z</datestamp><setSpec>com_10366_137251</setSpec><setSpec>com_10366_4512</setSpec><setSpec>com_10366_3823</setSpec><setSpec>col_10366_137252</setSpec></header><metadata><d:DIDL xmlns:d="urn:mpeg:mpeg21:2002:02-DIDL-NS" xmlns:doc="http://www.lyncode.com/xoai" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="urn:mpeg:mpeg21:2002:02-DIDL-NS http://standards.iso.org/ittf/PubliclyAvailableStandards/MPEG-21_schema_files/did/didl.xsd">
<d:DIDLInfo>
<dcterms:created xmlns:dcterms="http://purl.org/dc/terms/" xsi:schemaLocation="http://purl.org/dc/terms/ http://dublincore.org/schemas/xmls/qdc/dcterms.xsd">2024-02-06T09:38:00Z</dcterms:created>
</d:DIDLInfo>
<d:Item id="hdl_10366_155367">
<d:Descriptor>
<d:Statement mimeType="application/xml; charset=utf-8">
<dii:Identifier xmlns:dii="urn:mpeg:mpeg21:2002:01-DII-NS" xsi:schemaLocation="urn:mpeg:mpeg21:2002:01-DII-NS http://standards.iso.org/ittf/PubliclyAvailableStandards/MPEG-21_schema_files/dii/dii.xsd">urn:hdl:10366/155367</dii:Identifier>
</d:Statement>
</d:Descriptor>
<d:Descriptor>
<d:Statement mimeType="application/xml; charset=utf-8">
<oai_dc:dc xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:dc="http://purl.org/dc/elements/1.1/" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
<dc:title>Phenolic acids, cinnamic acid, and ergosterol as cosmeceutical ingredients: Stabilization by microencapsulation to ensure sustained bioactivity</dc:title>
<dc:creator>Taofiq, Oludemi</dc:creator>
<dc:creator>Heleno, Sandrina A.</dc:creator>
<dc:creator>Calhelha, Ricardo C.</dc:creator>
<dc:creator>Fernandes, Isabel P.</dc:creator>
<dc:creator>Alves, Maria José</dc:creator>
<dc:creator>Barros, Lillian Bouçada de</dc:creator>
<dc:creator>González Paramás, Ana María</dc:creator>
<dc:creator>Ferreira, Isabel C.F.R.</dc:creator>
<dc:creator>Barreiro, Maria F.</dc:creator>
<dc:subject>Bioactive compounds</dc:subject>
<dc:subject>Cosmeceuticals</dc:subject>
<dc:subject>Bioactive properties</dc:subject>
<dc:subject>Microencapsulation</dc:subject>
<dc:subject>Controlled release</dc:subject>
<dc:description>[EN] The global cosmetic industry is constantly searching for new ingredients with multifunctional properties. In this context, phenolic compounds (p-hydroxybenzoic, p-coumaric, and protocatechuic acids), cinnamic acid and ergosterol were evaluated for their anti-inflammatory, anti-tyrosinase and antimicrobial activities, and thereafter microencapsulated by the atomization/coagulation technique. After characterization (morphology, particle size distribution and encapsulation efficiency), the microencapsulated compounds were incorporated into a semi-solid base cream and their performance evaluated comparatively with the use of the free forms. The cosmeceutical formulations were checked regarding the presence of the bioactive compounds by HPLC-DAD, and for their physicochemical properties (colour and pH). The obtained results demonstrated the anti-tyrosinase, anti-inflammatory and antimicrobial activities of the individual compounds that, after incorporation, have shown a decreasing pattern along time. On the contrary, the formulations incorporating the microencapsulated bioactive compounds gave rise to a gradual release, ensuring bioactivity maintenance. These results underline the advantage of using microencapsulation to preserve and ensure the controlled release of bioactive species in cosmeceutical formulations.</dc:description>
<dc:date>2024-02-06T09:38:00Z</dc:date>
<dc:date>2024-02-06T09:38:00Z</dc:date>
<dc:date>2019</dc:date>
<dc:type>info:eu-repo/semantics/article</dc:type>
<dc:identifier>0026-265X</dc:identifier>
<dc:identifier>http://hdl.handle.net/10366/155367</dc:identifier>
<dc:identifier>10.1016/j.microc.2019.03.059</dc:identifier>
<dc:relation>https://doi.org/10.1016/j.microc.2019.03.059</dc:relation>
<dc:rights>info:eu-repo/semantics/openAccess</dc:rights>
</oai_dc:dc>
</d:Statement>
</d:Descriptor>
<d:Component id="10366_155367_1">
<d:Resource ref="https://gredos.usal.es/bitstream/10366/155367/1/Taofiq%20et%20al._2019_Microchemical%20Journal.pdf" mimeType="application/pdf"/>
</d:Component>
</d:Item>
</d:DIDL></metadata></record></GetRecord></OAI-PMH>